Integral fasciolicideOral Suspension
Triclabendazole 150 mg, excipients q.s. ad 1 mL.
For the treatment and control of Fasciola hepatica ("alicuya"), including cases of acute, subacute and chronic fasciolasis. Its action eliminates the mature and immature forms (including the early immature form) of Fasciola hepatica.
SENASA Registry: SENASA Perú: F.08.02.N.242